GlaxoSmithKline Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 22 July 2019.

Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2019, has recommended a Final dividend of Rs.20 per share (i.e.200%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharmaceuticals rose 16.56% to Rs 123.03 crore in the quarter ended March 2019 as against Rs 105.55 crore during the previous quarter ended March 2018. Sales rose 0.35% to Rs 751.22 crore in the quarter ended March 2019 as against Rs 748.62 crore during the previous quarter ended March 2018.

For the full year,net profit rose 20.85% to Rs 425.36 crore in the year ended March 2019 as against Rs 351.98 crore during the previous year ended March 2018. Sales rose 8.94% to Rs 3128.53 crore in the year ended March 2019 as against Rs 2871.69 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2019.

Powered by Capital Market - Live News